IL138330A0 - Polynucleotides, polypeptides and pharmaceutical compositions for treating lung cancer - Google Patents
Polynucleotides, polypeptides and pharmaceutical compositions for treating lung cancerInfo
- Publication number
- IL138330A0 IL138330A0 IL13833099A IL13833099A IL138330A0 IL 138330 A0 IL138330 A0 IL 138330A0 IL 13833099 A IL13833099 A IL 13833099A IL 13833099 A IL13833099 A IL 13833099A IL 138330 A0 IL138330 A0 IL 138330A0
- Authority
- IL
- Israel
- Prior art keywords
- polypeptides
- lung cancer
- pharmaceutical compositions
- polynucleotides
- treating lung
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4080298A | 1998-03-18 | 1998-03-18 | |
US09/040,984 US6210883B1 (en) | 1998-03-18 | 1998-03-18 | Compounds and methods for diagnosis of lung cancer |
US12393398A | 1998-07-27 | 1998-07-27 | |
US09/123,912 US6312695B1 (en) | 1998-03-18 | 1998-07-27 | Compounds and methods for therapy of lung cancer |
PCT/US1999/005798 WO1999047674A2 (en) | 1998-03-18 | 1999-03-17 | Compounds and methods for therapy and diagnosis of lung cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
IL138330A0 true IL138330A0 (en) | 2001-10-31 |
Family
ID=27488687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13833099A IL138330A0 (en) | 1998-03-18 | 1999-03-17 | Polynucleotides, polypeptides and pharmaceutical compositions for treating lung cancer |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1064372B1 (no) |
JP (1) | JP2002533056A (no) |
CN (1) | CN1299414A (no) |
AT (1) | ATE345387T1 (no) |
AU (1) | AU3094999A (no) |
BR (1) | BR9908823A (no) |
CA (1) | CA2323093A1 (no) |
DE (1) | DE69933998T2 (no) |
ES (1) | ES2277432T3 (no) |
IL (1) | IL138330A0 (no) |
NO (1) | NO20004631L (no) |
NZ (1) | NZ506699A (no) |
WO (1) | WO1999047674A2 (no) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6458349B1 (en) | 1995-06-02 | 2002-10-01 | Human Genome Sciences, Inc. | Chemokine β-4 polypeptides |
US6391589B1 (en) | 1994-08-23 | 2002-05-21 | Human Genome Sciences, Inc. | Human chemokine beta-10 mutant polypeptides |
US6174995B1 (en) | 1994-08-23 | 2001-01-16 | Haodong Li | Human chemokines, CKβ4 and CKβ10/MCP-4 |
US7338937B2 (en) * | 1997-11-17 | 2008-03-04 | Cornell Research Foundation, Inc. | Calcium-activated chloride channel proteins and their use in anti-metastatic therapy |
AU2577699A (en) | 1998-02-06 | 1999-08-23 | Human Genome Sciences, Inc. | Human serine protease and serpin polypeptides |
US7579160B2 (en) | 1998-03-18 | 2009-08-25 | Corixa Corporation | Methods for the detection of cervical cancer |
US6426072B1 (en) | 2000-08-02 | 2002-07-30 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US6737514B1 (en) | 1998-12-22 | 2004-05-18 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US20040235072A1 (en) * | 1998-03-18 | 2004-11-25 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US6706262B1 (en) | 1998-03-18 | 2004-03-16 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
US6960570B2 (en) | 1998-03-18 | 2005-11-01 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US6531315B1 (en) | 1998-03-18 | 2003-03-11 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US6696247B2 (en) | 1998-03-18 | 2004-02-24 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
US6482597B1 (en) | 1999-12-17 | 2002-11-19 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
US6518256B1 (en) | 1998-03-18 | 2003-02-11 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
US6660838B1 (en) | 1998-03-18 | 2003-12-09 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
US7258860B2 (en) | 1998-03-18 | 2007-08-21 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US6312695B1 (en) | 1998-03-18 | 2001-11-06 | Corixa Corporation | Compounds and methods for therapy of lung cancer |
US6821518B1 (en) | 1998-03-18 | 2004-11-23 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
US7049063B2 (en) | 1998-03-18 | 2006-05-23 | Corixa Corporation | Methods for diagnosis of lung cancer |
EP1847607B1 (en) | 1998-03-27 | 2011-06-08 | Otsuka Pharmaceutical Co., Ltd. | Antibodies against the p51 protein |
DE19822985C1 (de) * | 1998-05-25 | 2000-01-13 | Fraunhofer Ges Forschung | Tumorsuppressorgene der p53-Familie |
US6528054B1 (en) * | 1998-12-28 | 2003-03-04 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
WO2000052204A2 (en) | 1999-02-22 | 2000-09-08 | Orntoft Torben F | Gene expression in bladder tumors |
CZ20013527A3 (cs) * | 1999-04-02 | 2002-10-16 | Corixa Corporation | Sloučeniny a způsoby pro terapii a diagnostiku karcinomu plic |
DE19924199A1 (de) * | 1999-05-27 | 2000-11-30 | Boehringer Ingelheim Int | Tumorassoziiertes Antigen |
WO2001016324A2 (en) * | 1999-08-31 | 2001-03-08 | Board Of Regents, The University Of Texas System | Methods and compositions of a novel serine protease inhibitor |
WO2001029217A2 (en) * | 1999-10-15 | 2001-04-26 | Curagen Corporation | Novel polypeptides and polynucleotides encoding same |
US6855806B1 (en) | 1999-10-15 | 2005-02-15 | Curagen Corporation | Thymosin beta 10-like proteins and nucleic acids encoding same |
US6992170B2 (en) | 1999-10-15 | 2006-01-31 | Curagen Corporation | Polypeptides and polynucleotides homologous to thymosin, ephrin a receptors, and fibromodulin |
CA2392472A1 (en) * | 1999-11-24 | 2001-05-31 | Takeda Chemical Industries, Ltd. | Use of disease-associated gene |
EP1290171A2 (en) * | 2000-05-26 | 2003-03-12 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
WO2001096389A2 (en) * | 2000-06-09 | 2001-12-20 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of colon cancer |
US7214781B2 (en) | 2000-06-21 | 2007-05-08 | Hitachi Chemical Research Center, Inc. | Gene markers for lung cancer |
AU2001273149A1 (en) * | 2000-06-28 | 2002-01-08 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
AU2001273127A1 (en) * | 2000-06-29 | 2002-01-14 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US7141365B2 (en) | 2001-05-18 | 2006-11-28 | Syntex (U.S.A.) Llc | Methods for diagnosing a mucin production associated disease condition |
JP4098236B2 (ja) * | 2001-08-24 | 2008-06-11 | 久光製薬株式会社 | 肝芽腫と正常肝で発現差がある核酸 |
AU2003225237A1 (en) | 2002-05-01 | 2003-11-17 | Human Genome Sciences, Inc. | Antibodies that specifically bind to chemokine beta-4 |
EA026732B1 (ru) * | 2009-06-11 | 2017-05-31 | Минерва Байотекнолоджиз Корпорейшн | Способы культивирования стволовых клеток и клеток-предшественников |
SG10201509499RA (en) | 2010-11-19 | 2015-12-30 | Eisai R&D Man Co Ltd | Neutralizing anti-ccl20 antibodies |
CN114410644B (zh) * | 2022-01-31 | 2024-05-17 | 奥明(杭州)生物医药有限公司 | 一种环状rna分子及应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5589579A (en) * | 1994-07-19 | 1996-12-31 | Cytoclonal Pharmaceutics, Inc. | Gene sequence and probe for a marker of non-small cell lung carinoma |
US5633161A (en) * | 1995-03-29 | 1997-05-27 | Millennium Pharmaceuticals, Inc. | Murine gene fomy030 coding for tumor progression inhibitor |
-
1999
- 1999-03-17 IL IL13833099A patent/IL138330A0/xx unknown
- 1999-03-17 CA CA002323093A patent/CA2323093A1/en not_active Abandoned
- 1999-03-17 JP JP2000536857A patent/JP2002533056A/ja active Pending
- 1999-03-17 EP EP99912607A patent/EP1064372B1/en not_active Expired - Lifetime
- 1999-03-17 ES ES99912607T patent/ES2277432T3/es not_active Expired - Lifetime
- 1999-03-17 AU AU30949/99A patent/AU3094999A/en not_active Abandoned
- 1999-03-17 AT AT99912607T patent/ATE345387T1/de not_active IP Right Cessation
- 1999-03-17 WO PCT/US1999/005798 patent/WO1999047674A2/en active IP Right Grant
- 1999-03-17 BR BR9908823-1A patent/BR9908823A/pt not_active Application Discontinuation
- 1999-03-17 DE DE69933998T patent/DE69933998T2/de not_active Expired - Fee Related
- 1999-03-17 NZ NZ506699A patent/NZ506699A/en unknown
- 1999-03-17 CN CN99805693A patent/CN1299414A/zh active Pending
-
2000
- 2000-09-15 NO NO20004631A patent/NO20004631L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ATE345387T1 (de) | 2006-12-15 |
EP1064372A2 (en) | 2001-01-03 |
NO20004631L (no) | 2000-11-15 |
WO1999047674A2 (en) | 1999-09-23 |
WO1999047674A3 (en) | 2000-01-20 |
ES2277432T3 (es) | 2007-07-01 |
NO20004631D0 (no) | 2000-09-15 |
JP2002533056A (ja) | 2002-10-08 |
DE69933998T2 (de) | 2007-10-04 |
EP1064372B1 (en) | 2006-11-15 |
CA2323093A1 (en) | 1999-09-23 |
CN1299414A (zh) | 2001-06-13 |
AU3094999A (en) | 1999-10-11 |
BR9908823A (pt) | 2000-11-21 |
NZ506699A (en) | 2003-12-19 |
DE69933998D1 (de) | 2006-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL138330A0 (en) | Polynucleotides, polypeptides and pharmaceutical compositions for treating lung cancer | |
PL354348A1 (en) | Compounds and methods for therapy and diagnosis of lung cancer | |
WO1999038973A3 (en) | Compounds for therapy and diagnosis of lung cancer and methods for their use | |
TW581808B (en) | Compounds for immunotherapy of prostate cancer and methods for their use | |
WO1999033869A3 (en) | Compounds for immunotherapy and diagnosis of breast cancer and methods for their use | |
WO1998037093A3 (en) | Compounds for immunotherapy of prostate cancer and methods for their use | |
IL153996A0 (en) | Polypeptides containing at least a portion of an ovarian carcinoma protein, polynucleotides encoding the same and pharmaceutical compositions containing the same | |
NZ516381A (en) | Lung tumor proteins in the therapy and diagnosis of lung cancer | |
PL314239A1 (en) | Recombinated adenovirus vector and method of using it | |
HUP0203035A2 (hu) | Prosztatarák terápiájára és diagnózisára alkalmas vegyületek és eljárások | |
NZ512247A (en) | Compositions and methods for therapy and diagnosis of ovarian cancer | |
WO1997025426A3 (en) | Compositions and methods for the treatment and diagnosis of breast cancer | |
WO1996040039A3 (en) | Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof | |
WO2000061756A3 (en) | Compounds for immunotherapy and diagnosis of breast cancer and methods for their use | |
WO1998045328A3 (en) | Compositions and methods for the treatment and diagnosis of breast cancer | |
CA2234263A1 (fr) | Composition pharmaceutique contre les tumeurs et infections a papillomavirus | |
WO2001018046A3 (en) | Ovarian tumor sequences and methods of use therefor | |
WO1999037775A3 (en) | Compositions and methods for detecting and treating breast cancer | |
EP2003201A3 (en) | Compounds and methods for therapy and diagnosis of lung cancer | |
EP1351967A4 (en) | COMPOSITIONS AND METHODS FOR THERAPY AND DIAGNOSIS OF LUNG CANCER | |
AU3797301A (en) | 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer | |
WO1999054466A3 (en) | Colon cancer-associated antigens and their diagnostic and therapeutic uses | |
CO5050254A1 (es) | Compuestos para el tratamiento y diagnostico del cancer de pulmon | |
WO1999037778A3 (en) | Compositions and methods for detecting and treating prostate cancer | |
CO5241295A1 (es) | Compuestos para inmunoterapia y para el diagnostico del can- cer de mama y metodos para su utilizacion |